Physician profile
Marla Close
NPI 1962959890
$576.01
in general payments reported to CMS, 2019-2025
16 companies · $53.07 in 2025
The $53.07 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.56 · 2021: $225 · 2022: $92.82 · 2023: $57.90 · 2024: $86.56 · 2025: $53.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $183 · Entertainment: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $182.53 |
| Entertainment | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivantis, INC | $122.28 | 2021 | |
| Abbvie INC. | $67.54 | 2024-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $63.73 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $53.98 | 2024 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $42.77 | 2021-2022 | |
| Alcon Vision LLC | $36.94 | 2022 | |
| Mallinckrodt Hospital Products INC. | $29.79 | 2023 | Acthar |
| Rayner Intraocular Lenses Limited | $26.56 | 2022-2023 | Rayone Emv, Omidria, Rayone Aspheric |
| Allergan, INC. | $20.84 | 2022 | |
| Aerie Pharmaceuticals, INC. | $18.74 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $18.71 | 2019 | |
| Amgen INC. | $18.11 | 2025 | Tepezza |
| Optos, INC. | $15.00 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Tearlab Corp | $14.10 | 2021 | |
| Ocular Therapeutix, INC. | $13.98 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $12.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marla Close listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.